Marks & Clerk Life Sciences Report 2015 was published on 16 June and launched at the 2015 BIO International Convention in Philadelphia.
The report examines the state of innovation in treatments for rare diseases and for widespread conditions. We have been through a decade of intense research into treatments for rare diseases, thanks in large part to the many government incentives in place to encourage investment and R&D.
Meanwhile, as the problem of antibiotic resistance attracts more and more headlines, levels of research into new classes of antibiotics remain low. Vaccines continue to prove a vital tool in the prevention of widespread conditions, although we are now also seeing a growing focus on therapeutic vaccines.
In this year's report, Marks & Clerk have reviewed patent filing data over the last decade in these three key areas; medicines for rare diseases, vaccines and antibiotics.
Each showed distinct trends in terms of filing volumes and the patent applicants themselves. The authors conclude that "we hope that in another 10 years' time, the story will have move on significantly".
Read the report by clicking here.